In This Section

Division for Cardiovascular Pharmacology (CVP)

The Division for Cardiovascular Pharmacology (CVP) serves members with interests in all aspects of cardiovascular pharmacology research from the molecular level to whole animal and clinical studies. Specific areas include, but are not limited to, mechanisms of cardiovascular drug action, autonomic pharmacology, cell signaling, cardiac pharmacology, endothelial and smooth muscle cell pharmacology, hemostasis and thrombosis, blood vessel wall interactions, and mechanisms involved in the pathogenesis, diagnosis and treatment of cardiac, renal, pulmonary and cerebral vascular disease, including hypertension, coronary artery disease and stroke.

Division Goals

  • To promote discovery, dissemination of knowledge, and advances in the field of cardiovascular pharmacology.
  • To increase communication among members of the CVP Division.
  • To meet at the annual Experimental Biology meeting to discuss past accomplishments of the division and share future ideas and directions that are important to cardiovascular pharmacology.
  • To promote and strengthen collaboration and connections between the CVP Division and other ASPET divisions as well as with other national societies such as FASEB and The American Physiological Society.
  • To foster professional development by encouraging CVP Division trainees and faculty to take an active role on committees and symposia organization.
  • To recognize member achievements in division public announcements and through active awards programs

Division News

Last Updated: August 3, 2017

Job Postings